摘要
恶性肿瘤是静脉血栓栓塞症（VTE）的高危因素之一。最近一项尸检报告约80％的致命性肺栓塞发生在内科肿瘤患者；外科患者中VTE已成为肿瘤术后患者30d内的首要死亡原因，远远超过术后出血所致的死亡。FRONTLINE研究表明只有50％的肿瘤外科医师和5％的肿瘤内科医师对肿瘤患者实施了VTE预防，而我国肿瘤相关VTE的预防则处于刚刚起步阶段。推动肿瘤患者院内、院外规范化的血栓预防是目前我国肿瘤内、外科医师所面临的紧迫问题。本文就肿瘤合并VTE的流行病学、风险评估和院内、院外肿瘤患者VTE预防的具体措施做了系统阐述。
Malignant tumor is one of the risk factors for venous thromboembolism （VTE）. A recent autopsy reported that about 80% of fatal pulmonary embolism occurred in patients with tumor in department of internal medicine. VTE has become the first cause of death within 30d after patients received tumors operation,and outdistance the mortality of bleeding after operation. FRONTLINE study showed that only 50% oncologieal surgery doctors and 5% physicians of cancer made prevention of VTE in cancer patients. But in china prevention of cancer-related VTE is iust in the initial stage. So,it is the urgent problem for physicians and surgeons of cancer to promote standardized thromboprophylaxis in/out hospital in cancer patients at present in china. This article formulates the epidemiology, risk assessment of cancer-related VTE,and specific measures to prevention of cancer-related VTE in/out hospital.
出处
《国际呼吸杂志》
2014年第8期611-616,共6页
International Journal of Respiration
关键词
恶性肿瘤
静脉血栓栓塞症
抗凝
预防
Malignant tumor
Venous thromboembolism
Anticoagulation
Prevention
